Toumaz Technology Debuts New Multi-Function Sensium Module

Toumaz Technology LimitedToumaz Technology Limited has announced the first availability of the Sensiumâ„¢ modular system, a new ultra-low power wireless infrastructure for health and lifestyle monitoring applications. The wireless-enabled modules, based on Toumaz's ultra-low power Zoum transceiver platform, are being made available now to key customers. The first demonstration of the new modular system took place on the Oracle stand at The World of Health IT Conference and Exhibition in Geneva, Switzerland (Geneva Palexpo, 10th-13th October 2006, Oracle stand #315).

The ultra small size body-worn module can be attached to the body with a sticking plaster to enable non-intrusive, continuous monitoring and analysis of the mobile individual's ECG, temperature, and at least one other vital sign such as respiration or activity level. The wearable sensor module incorporates Toumaz's ultra low power Zoum RF transceiver to create a wireless data link and transmit personal readings on to a Zoum-enabled SD card or USB module. The SD card plugs into any standard PDA or cellphone running Windows Mobile 5, allowing the ECG, temperature and other vital sign data to be received, processed and displayed via Toumaz's ECGSoft application software. A sophisticated, real-time arrhythmia detection algorithm continuously analyses the incoming data to provide an intelligent ECG monitoring capability.

Due to the ultra low power Zoum transceiver, incorporating both RF and baseband functionality such as framing, error correction and link protocol, the body-worn Sensium module is able to be manufactured in a small, non-intrusive form factor that can use a small, low cost zinc-air battery to provide multi-function continuous monitoring for an average of five days.

"The Sensium module is delivering the wireless infrastructure for a new wave of personalised care applications, and is now set to enable a real revolution in areas such as continuous vital sign monitoring," commented Toumaz COO, Keith Errey. "By integrating with standard mobile devices such as PDAs and cellphones, the Sensium is defining new possibilities for low cost, disposable monitoring solutions for a whole range of healthcare applications, including 'at risk', post-operative and home monitoring".

The 'digital plaster' concept pioneered by Toumaz has attracted significant interest within the healthcare market. Toumaz Chairman and Chief Technology Officer, Professor Chris Toumazou delivered an e-Session on Pervasive Monitoring Technologies for Personalised Healthcare at The World of Health IT Conference and Exhibition in Geneva.

For further information, please visit:
www.toumaz.com/healthcare/

Related news articles:

About Toumaz Technology
Toumaz Technology Limited is a developer of advanced RF, analogue and mixed signal semiconductors. The focus of the business is low power devices based on the company's proprietary AMx (Advanced Mixed Signal) technology which addresses the needs of lower power consumption for mobile and wirelessly connected systems.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...